Back to Authors

Gendron, Tania F.

https://orcid.org/0000-0002-7335-2627

Mayo Clinic

Mayo Clinic

Citations 76

O4‐03‐02: Progranulin regulates neuronal morphology through activation of ERK pathway
Gass, Jennifer , Lee, Cheung, Petrucelli, Leonard , Gendron, Tania F.

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2011.05.1981 Get It

P3‐209: Pitavastatin decreases tau levels via the inactivation of Rho family small G proteins
Yen, Shu‐Hui, Ko, Li‐wen, Shirafuji, Norimichi, Yoneda, Makoto , Kuriyama, Masaru, Hamano, Tadanori , Gendron, Tania F.

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2011.05.1650 Get It

P1‐372: Regulation of the Hsp90 chaperone complex by HDAC6
Cook, Casey , Dunmore, Judy H., DeTure, Michael , Petrucelli, Leonard , Gendron, Tania F.

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_9 | Pages: No page available

10.1016/j.jalz.2010.05.926 Get It

P1‐185: Wild‐type human TDP‐43 induces mitochondrial abnormalities and axonal degeneration in transgenic mice
Xu, Yafei , Lin, Wen-Lang, D’Alton, Simon , Sheng, Hong, Casey, Monica Castanedes, Tong, Jimei, Yu, Xin , Rademakers, Rosa , Hutton, Mike, Petrucelli, Leonard , Lewis, Jada , Gendron, Tania F. , Zhang, Yong‐Jie , Sheng, Hong, Crook, Richard , Knight, Joshua A. , Boylan, Khrista , McGowan, Eileen , Dickson, Dennis W.

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_8 | Pages: No page available

10.1016/j.jalz.2010.05.735 Get It

P1‐165: Generation and characterization of FTLD‐U and ALS cell model with inducible expression of TDP‐43 C‐terminal fragment
Xu, Yafei , Ko, Li‐wen, Yen, Shu‐Hui, Petrucelli, Leonard , Zhang, Yongjie , Gendron, Tania F.

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2010.05.715 Get It

Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
Zhang, Yong‐Jie , Xu, Ya-Fei, Cook, Casey , Roettges, Paul S., Link, Christopher D. , Lin, Wen-Lang, Tong, Jimei, Castanedes‐Casey, Monica , Ash, Peter E.A. , Gass, Jennifer , Rangachari, Vijayaraghavan , Buratti, Emanuele , Golde, Todd E. , Dickson, Dennis W. , Petrucelli, Leonard , Gendron, Tania F. , Baralle, Francisco Ernesto , Zhang, Yong-Jie , Dickson, Dennis W

Proceedings of the National Academy of Sciences | April 21, 2009 | Volume: 106 | Issue: 18 | Pages: 7607-7612

10.1073/pnas.0900688106 Get It

Inclusions of TAR DNA-binding protein-43 (TDP-43), a nuclear protein that regulates transcription and RNA splicing, are the defining histopathological feature of frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-Us) and sporadic and familial forms of amyotrophic lateral sclerosis (ALS). In ALS and FTLD-U, aggregated, ubiquitinated, and N-terminally truncated TDP-43 can be isolated from brain tissue rich in neuronal and glial cytoplasmic inclusions. The loss of TDP-43 function resulting from inappropriate cleavage, translocation from the nucleus, or its sequestration into inclusions could play important roles in neurodegeneration. However, it is not known whether TDP-43 fragments directly mediate toxicity and, more specifically, whether their abnormal aggregation is a cause or consequence of pathogenesis. We report that the ectopic expression of a ≈25-kDa TDP-43 fragment corresponding to the C-terminal truncation product of caspase-cleaved TDP-43 leads to the formation of toxic, insoluble, and ubiquitin- and phospho-positive cytoplasmic inclusions within cells. The 25-kDa C-terminal fragment is more prone to phosphorylation at S409/S410 than full-length TDP-43, but phosphorylation at these sites is not required for inclusion formation or toxicity. Although this fragment shows no biological activity, its exogenous expression neither inhibits the function nor causes the sequestration of full-length nuclear TDP-43, suggesting that the 25-kDa fragment can induce cell death through a toxic gain-of-function. Finally, by generating a conformation-dependent antibody that detects C-terminal fragments, we show that this toxic cleavage product is specific for pathologic inclusions in human TDP-43 proteinopathies.